Acadia Q4 EPS Beats by 31% with $283.99M Revenue, YTD Shares Down 7.9%
Acadia reported Q4 EPS of $0.16, beating consensus by 31% but down from $0.17 a year ago, while revenue rose to $283.99M, missing estimates by 2.9%. Shares have declined 7.9% year-to-date despite four consecutive quarters of earnings surprises.
1. Q4 Performance
Acadia delivered adjusted earnings of $0.16 per share for the quarter ended December 2025, topping the $0.12 consensus by 31% but down from $0.17 in the prior-year period. Revenue climbed 9.5% to $283.99 million, falling 2.9% short of analyst estimates.
2. Consecutive Surprise Streak
This marks the fourth straight quarter in which the company has exceeded earnings forecasts, sustaining a pattern of upside surprises. The consistency underscores management’s ability to manage costs and extract value from its existing product portfolio.
3. YTD Share Performance
Despite the earnings outperformance, shares have slipped 7.9% since January as broader market gains in the healthcare sector outpaced the company. Underperformance reflects investor caution over near-term growth drivers and pipeline catalysts.
4. Outlook and Estimates
Consensus for the March quarter stands at $0.16 EPS on $268.17 million in revenue, while full-year expectations call for $0.68 EPS on $1.19 billion. Future stock momentum will hinge on estimate revisions and management commentary during the upcoming earnings call.